Log in to save to my catalogue

A novel small-molecular CCR5 antagonist promotes neural repair after stroke

A novel small-molecular CCR5 antagonist promotes neural repair after stroke

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10545720

A novel small-molecular CCR5 antagonist promotes neural repair after stroke

About this item

Full title

A novel small-molecular CCR5 antagonist promotes neural repair after stroke

Publisher

Singapore: Springer Nature Singapore

Journal title

Acta pharmacologica Sinica, 2023-10, Vol.44 (10), p.1935-1947

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Scope and Contents

Contents

Chemokine receptor 5 (CCR5) is one of the main co-receptors of HIV-1, and has been found to be a potential therapeutic target for stroke. Maraviroc is a classic CCR5 antagonist, which is undergoing clinical trials against stroke. As maraviroc shows poor blood-brain barrier (BBB) permeability, it is of interest to find novel CCR5 antagonists suitabl...

Alternative Titles

Full title

A novel small-molecular CCR5 antagonist promotes neural repair after stroke

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10545720

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10545720

Other Identifiers

ISSN

1671-4083,1745-7254

E-ISSN

1745-7254

DOI

10.1038/s41401-023-01100-y

How to access this item